Status:
COMPLETED
Catheter-Based Treatment of Cardiovascular Disease
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Obstructive Coronary Artery Disease
Obstructive Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study offers catheter-based treatment of heart or artery disease. This protocol permits treatment of patients with cardiovascular diseases who may not be eligible to participate in current resear...
Detailed Description
The NHLBI is developing novel minimally invasive catheter-based treatments for cardiovascular disease. These investigational treatments require that physicians, nurses and technical staff maintain and...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Adult men and women with cardiovascular disease will be eligible to participate in this training protocol.
- Adult men and women, age 18 years or older
- Eligible for catheter-based treatment. A representative list of diseases and catheter-based treatments includes:
- Obstructive coronary artery disease manifest as myocardial infarction, angina pectoris, angina-equivalent, ischemic dysrhythmia, or evidence of ischemia or viability on non-invasive cardiovascular testing
- Obstructive peripheral artery disease manifest as intermittent claudication, limb-threatening ischemia, visceral ischemia, or obstructive extracranial cerebrovascular disease
- Structural heart disease including patent foramen ovale, atrial septal defect, ventricular septal defect, patent ductus arteriosus, and valvular heart disease
- EXCLUSION CRITERIA:
- Subjects are excluded if catheter-based therapy is unsuitable, in the opinion of the operating cardiologist.
- Pregnant women
- Inability of patient or surrogate to provide informed consent.
Exclusion
Key Trial Info
Start Date :
September 20 2006
Trial Type :
INTERVENTIONAL
End Date :
March 3 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00380016
Start Date
September 20 2006
End Date
March 3 2009
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892